# A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma

> **NCT05481437** · — · RECRUITING · sponsor: **Takeda** · enrollment: 8 (estimated)

## Conditions studied

- Hodgkin Lymphoma

## Interventions

- **DRUG:** Brentuximab Vedotin

## Key facts

- **NCT ID:** NCT05481437
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2022-08-01
- **Primary completion:** 2027-07-31
- **Final completion:** 2027-07-31
- **Target enrollment:** 8 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05481437

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05481437, "A Survey of Brentuximab Vedotin in Pediatric Participants With Hodgkin Lymphoma". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05481437. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*